Literature DB >> 32162877

Platelet miR-587 may be Used as a Potential Biomarker for Diagnosis of Patients with Acute Coronary Syndrome.

Hao Qiu, Yangyang Zhang, Qiang Zhao, Huaxin Jiang, Jingpeng Yan, Yanyan Liu.   

Abstract

BACKGROUND: The current study aims to investigate the expression of miR-587 in platelets of patients with acute coronary syndrome (ACS) and its correlation with the severity of coronary artery disease.
METHODS: One hundred thirty-nine patients with ACS who underwent coronary angiography (CAG) and hospitalized in the Department of Cardiology of Affiliated Tengzhou Central People's Hospital of Jining Medical University were selected. In addition, 42 subjects with normal CAG results were selected as the control group. The relative expression of platelet miR-587 was analyzed between ACS patients and control subjects.
RESULTS: The relative expression of platelet miR-587 and Gensini score in acute myocardial infarction (AMI) patients were significantly higher than those in the unstable angina pectoris (UA) and control groups (median (IQR): 1.97 (0.47) vs. 1.49 (0.43) vs. 1.04 (0.35); 65.07 (21.6) vs. 44.58 (28.56) vs. 13.67 (11.8)). Furthermore, the relative level of miR-587 in ACS patients with three vessel lesions was significantly higher than those with double vessel le-sion and single vessel lesion (2.68 (0.64) vs. 1.85 (0.53) vs. 1.22 (0.40)). Additionally, the relative expression of platelet miR-587 in patients with severe coronary artery disease was significantly higher than in those with moderate or mild coronary artery disease (2.44 (0.59) vs. 1.70 (0.49) vs. 0.96 (0.32)). Pearson's correlation analysis showed that the Gensini score and creatine kinase isoenzyme (CK-MB) of ACS patients were positively correlated with the expression of platelet miR-587 (r = 0.785, p = 0.000; r = 0.806, p = 0.000).
CONCLUSIONS: The expression of platelet miR-587 was closely related to the severity of coronary artery stenosis and could be used as a potential target for diagnosis or prognosis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32162877     DOI: 10.7754/Clin.Lab.2019.190703

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  4 in total

Review 1.  Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target.

Authors:  Qianru Leng; Jie Ding; Meiyan Dai; Lei Liu; Qing Fang; Dao Wen Wang; Lujin Wu; Yan Wang
Journal:  Front Cardiovasc Med       Date:  2022-06-09

2.  lncRNA PANTR1 Upregulates BCL2A1 Expression to Promote Tumorigenesis and Warburg Effect of Hepatocellular Carcinoma through Restraining miR-587.

Authors:  Xirui Ma; Ziming Mao; Jing Zhu; Huifang Liu; Fengling Chen
Journal:  J Immunol Res       Date:  2021-08-12       Impact factor: 4.818

3.  microRNA-3646 serves as a diagnostic marker and mediates the inflammatory response induced by acute coronary syndrome.

Authors:  Jinming Yu; Yongmei Li; Deguo Leng; Cheng Cao; Yongzhi Yu; Yijuan Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention.

Authors:  Tao Chen; Xueshan Zhang; Wei Qian; Ran Zhou; Mingyu Su; Yanfeng Ma
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.